<DOC>
	<DOCNO>NCT01576757</DOCNO>
	<brief_summary>The purpose study determine whether harvest , isolation culture cardiac stem cell endomyocardial biopsy feasible .</brief_summary>
	<brief_title>Harvest , Isolation Culture Cardiac Stem Cells From Endomyocardial Biopsies</brief_title>
	<detailed_description>Heart failure devastate condition affect nearly 6 million patient United States alone . Ischemic cardiomyopathy , pump failure secondary previous heart attack , consider many lead cause heart failure . Stem cell therapy , regeneration lose myocardium , intervention potential reverse detrimental effect disease . Recently publish evidence show preliminary result indicate safety feasibility utilizing cardiac stem cell treatment ischemic cardiomyopathy . The ability use commonly practice method , endomyocardial biopsy , isolate expand stem cell culture could , potentially , make therapy widely available . The result study important design future clinical trial .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Any heart failure patient schedule RHC without contraindication biopsy . 2 . Any patient undergoing biopsy diagnostic purpose may also include study . 1 . Severe comorbidities ( AST , ALT , serum creatinine &gt; 3 time upper limit normal ) . 2 . Pregnancy woman childbearing potential . 3 . Anticoagulation stop 57 day . 4 . Hepatitis B , C HIV . 5 . Inability give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Stem cell therapy</keyword>
</DOC>